|
Report ID
|
67310 |
|
Drug Identification Number
|
02230737 |
|
Brand name
|
LOSEC 10 MG |
|
Common or Proper name
|
omeprazole magnesium delayed release tablets |
|
Company Name
|
ASTRAZENECA CANADA INC |
|
Market Status
|
CANCELLED POST MARKET |
|
Active Ingredient(s)
|
OMEPRAZOLE |
|
Strength(s)
|
10MG |
|
Dosage form(s)
|
TABLET (DELAYED-RELEASE) |
|
Route of administration
|
ORAL |
|
Packaging size
|
2 x 15 |
|
ATC code
|
A02BC |
|
ATC description
|
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
|
Reason for shortage
|
Other (Please describe in comments) |
|
Anticipated start date
|
2018-12-14 |
|
Actual start date
|
2018-12-14 |
|
Estimated end date
|
Unknown |
|
Actual end date
|
|
|
Shortage status
|
Actual shortage |
|
Updated date
|
2019-11-18 |
|
Company comments
|
The product will be discontinued as of November 16, 2019. |
|
Health Canada comments
|
|
|
Tier 3 Status
|
No |
| Company contact information |
Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected]. |
